title: Evaluation of serum haptoglobin levels in patients with adnexal masses.
abstract: Over a four-year period, serum haptoglobin was measured in 152 patients with adnexal masses in an attempt to discriminate between benign and malignant disease. When serum haptoglobin exceeded 150 mg/dl, malignancy could be identified with a sensitivity of 83% and a specificity of 84%. While the predictive value of a positive test is only 66%, the predictive value of a negative test is 93%, and this inexpensive test may be clinically useful. Stage, grade, and size of tumor did not correlate with serum haptoglobin levels.
authors.forename: S
authors.initials: S
authors.lastname: Elg
authors.forename: R B
authors.initials: RB
authors.lastname: Lee
authors.forename: C
authors.initials: C
authors.lastname: Stones
authors.forename: P J
authors.initials: PJ
authors.lastname: Webber
authors.forename: W L
authors.initials: WL
authors.lastname: Benson
mesh_terms: D000290:Adnexa Uteri; D005260:Female; D005833:Genital Neoplasms, Female / Q000097:blood*; D006242:Haptoglobins / Q000032:analysis*; D006801:Humans; D011237:Predictive Value of Tests
chemical_list: D006242:Haptoglobins